Assembly Bill 68 seeks to amend the prescription drug monitoring program (PDMP) in Wisconsin by extending certain requirements related to the review of patient records and the evaluation of the program's outcomes. Specifically, the bill extends the requirement for practitioners to review a patient's records before issuing a prescription order from its current expiration date of April 1, 2025, to April 1, 2030. Additionally, it extends the mandate for the Controlled Substances Board to conduct a quarterly review of the PDMP, which is currently set to end on October 30, 2025, to October 30, 2030.

These amendments aim to enhance the oversight and effectiveness of the PDMP, ensuring that practitioners continue to assess patient records and that the board evaluates the program's performance over a longer period. The bill was introduced by Representative Dittrich and cosponsored by Senator Testin, and it has been referred to the Committee on Health, Aging and Long-Term Care for further consideration.

Statutes affected:
Bill Text: 961.385(2)(cs)1, 961.385, 961.385(5)(b), 961.385(6)(a)